Recon: Merck KGaA to buy SpringWorks for over $3B; US tariffs could increase drug spending by $51B per year
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States